XCel Brands, Inc.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
XELB$0.43+6.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Stockholders’ Equity
(in thousands, except share data)
| | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Xcel Brands, Inc. Stockholders · · · · · · · | ||||||||||||||||||
| · · Common Stock · · · · · · · · · · · | ||||||||||||||||||
| · · Number of · · · · · Paid-In · · Accumulated · · Noncontrolling · · · | ||||||||||||||||||
| · · Shares · · Amount · · Capital · · Deficit · · Interest · · · Total | ||||||||||||||||||
| Balance as of December 31, 2024 | 2,368,072 | | $2 | | $106,666 | | $(76,244) | | $(2,026) | | | $28,398 | ||||||
| | | | | | | | | | | | | | | | | | | |
| Additional impact related to fractional shares from reverse stock split | | (57) | | | — | | | — | | | — | | | — | | | | — |
| | | | | | | | | | | | | | | | | | | |
| Compensation expense related to stock options and restricted stock | | — | | | — | | | 33 | | | — | | | — | | | | 33 |
| | | | | | | | | | | | | | | | | | | |
| Contra-revenue related to warrants held by licensee | — | | — | | 10 | | — | | — | | | 10 | ||||||
| | | | | | | | | | | | | | | | | | | |
| Shares issued to executives for pro rata portion of base salaries, net of withholding taxes | | 18,310 | | | — | | | 66 | | | — | | | — | | | | 66 |
| | | | | | | | | | | | | | | | | | | |
| Net loss | — | | — | | — | | (2,797) | | | — | | | (2,797) | |||||
| | | | | | | | | | | | | | | | | | | |
| Balance as of March 31, 2025 | 2,386,325 | | | 2 | | | 106,775 | | | (79,041) | | | (2,026) | | | | 25,710 | |
| | | | | | | | | | | | | | | | | | | |
| Compensation expense related to stock options and restricted stock | | — | | | — | | | 54 | | | — | | | — | | | | 54 |
| | | | | | | | | | | | | | | | | | | |
| Contra-revenue related to warrants held by licensee | | — | | | — | | | 9 | | | — | | — | | | | 9 | |
| | | | | | | | | | | | | | | | | | | |
| Warrants issued and amended in connection with refinancing of term loan debt | | — | | | — | | | 648 | | | — | | | — | | | | 648 |
| | | | | | | | | | | | | | | | | | | |
| Shares issued to management and directors in connection with restricted stock grants | | 21,500 | | | — | | | — | | | — | | | — | | | | — |
| | | | | | | | | | | | | | | | | | | |
| Shares issued to executives for pro rata portion of base salaries, net of withholding taxes | | 29,675 | | | — | | | 66 | | | — | | | — | | | | 66 |
| | | | | | | | | | | | | | | | | | | |
| Net loss | — | | | — | | | — | | | (3,988) | | | (3) | | | | (3,991) | |
| | | | | | | | | | | | | | | | | | | |
| Balance as of June 30, 2025 | 2,437,500 | | $2 | | $107,552 | | $(83,029) | | $(2,029) | | | $22,496 | ||||||
| | | | | | | | | | | | | | | | | | | |
| Balance as of December 31, 2025 | 5,880,757 | | $6 | | $111,660 | | $(93,705) | | $(2,137) | | | $15,824 | ||||||
| | | | | | | | | | | | | | | | | | | |
| Compensation expense related to stock options and restricted stock | | — | | | — | | | 51 | | | — | | | — | | | | 51 |
| | | | | | | | | | | | | | | | | | | |
| Contra-revenue related to warrants held by licensee | | — | | | — | | | 10 | | | — | | | — | | | | 10 |
| | | | | | | | | | | | | | | | | | | |
| Shares issued to executive for pro rata portion of base salary, net of withholding taxes | | 32,735 | | | — | | | 43 | | | — | | | — | | | | 43 |
| | | | | | | | | | | | | | | | | | | |
| Costs incurred related to equity line facility | | — | | | — | | | (258) | | | — | | | — | | | | (258) |
| | | | | | | | | | | | | | | | | | | |
| Net loss | — | | — | | — | | (2,489) | | | — | | | (2,489) | |||||
| | | | | | | | | | | | | | | | | | | |
| Balance as of March 31, 2026 | 5,913,492 | | | 6 | | | 111,506 | | | (96,194) | | | (2,137) | | | | 13,181 | |
| | | | | | | | | | | | | | | | | | | |
| Compensation expense related to stock options and restricted stock | | — | | | — | | | 15 | | | — | | | — | | | | 15 |
| | | | | | | | | | | | | | | | | | | |
| Contra-revenue related to warrants held by licensee | — | | — | | 9 | | — | | — | | | 9 | ||||||
| | | | | | | | | | | | | | | | | | | |
| Shares issued in connection with issuance of Senior Secured Notes | | 100,579 | | | — | | | 121 | | | — | | | — | | | | 121 |
| | | | | | | | | | | | | | | | | | | |
| Shares issued as consideration for entry into equity line facility | | 16,094 | | | — | | | — | | | — | | | — | | | | — |
| | | | | | | | | | | | | | | | | | | |
| Shares issued under equity line facility, net | | 348,000 | | | — | | | 673 | | | — | | | — | | | | 673 |
| | | | | | | | | | | | | | | | | | | |
| Shares issued to service provider under marketing agreement | | 62,112 | | | — | | | 137 | | | — | | | — | | | | 137 |
| | | | | | | | | | | | | | | | | | | |
| Shares issued to directors in connection with restricted stock grants | | 5,000 | | | — | | | — | | | — | | | — | | | | — |
| | | | | | | | | | | | | | | | | | | |
| Shares issued to executive for pro rata portion of base salary, net of withholding taxes | | 29,905 | | | — | | | 62 | | | — | | | — | | | | 62 |
| | | | | | | | | | | | | | | | | | | |
| Net loss | — | | — | | — | | (2,476) | | | — | | | | (2,476) | ||||
| | | | | | | | | | | | | | | | | | | |
| Balance as of June 30, 2026 | 6,475,182 | | $6 | | $112,523 | | $(98,670) | | $(2,137) | | | $11,722 | ||||||
| | | | | | | | | | | | | | | | | | | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.